Why Employers Test for Opioids: Protecting Employees, Preventing Accidents, and Ensuring Compliance
- Ryan Cunningham
- Jul 18
- 2 min read

Opioid testing is more than a regulatory requirement; it's a proven workplace safety strategy. According to the U.S. Department of Transportation (DOT), employers regulated under 49 CFR Part 40 must test safety-sensitive employees for opioids because impairment can increase the risk of crashes, injuries, and fatalities. DOT testing screens for seven opioids: codeine, morphine, heroin metabolite (6-acetylmorphine), hydrocodone, hydromorphone, oxycodone, and oxymorphone, with every non-negative result reviewed by a certified Medical Review Officer (MRO) before being reported.
The need for opioid testing is supported by national data. According to SAMHSA's 2024 National Survey on Drug Use and Health, an estimated 8.9 million Americans aged 12 or older had an opioid use disorder in the past year. The White House Office of National Drug Control Policy (ONDCP) also reports that opioid misuse continues to be a major public health and workplace safety concern, contributing to thousands of preventable deaths and lost productivity each year.
For employers, opioid impairment can reduce reaction time, alertness, coordination, and decision-making; critical abilities for employees operating commercial vehicles, heavy equipment, machinery, or performing other safety-sensitive duties. The Office of Drug and Alcohol Policy and Compliance (ODAPC) emphasizes that federal drug testing programs help protect employees, passengers, and the public while supporting a safe, drug-free workplace.
The demand for workplace drug testing continues to rise. Industry market research projects the global workplace drug testing market will grow at a compound annual growth rate (CAGR) of approximately 5–7% through the next decade, driven by expanding transportation, construction, healthcare, manufacturing, and infrastructure industries, along with increasing employer investments in workplace safety and regulatory compliance.
For HR professionals, Designated Employer Representatives (DERs), and Safety Managers, opioid testing is more than checking a compliance box. It helps reduce workplace accidents, strengthen regulatory compliance, lower workers' compensation costs, decrease liability exposure, and reinforce a culture where every employee reports to work fit for duty. Investing in a compliant opioid testing program is an investment in safer employees, safer operations, and a stronger, drug-free workplace.



Comments